Cellife Rapid Flu Assay (Coming Soon)

Download the latest instructions for use

Cellife Rapid Flu Assay
Catalog No.: U20206

The Cellife Rapid Flu Assay is an automated in vitro nucleic acid amplification test for the rapid qualitative detection and differentiation of RNA from Influenza A and Influenza B viruses in human oropharyngeal (throat) swab specimens. It is intended for non-pandemic clinical detection only and should be used alongside clinical observations and epidemiological information to support diagnosis.

Product Overview

This assay is run on the EasyNAT System and automates the entire workflow — from nucleic acid extraction through amplification and fluorescence-based detection. It provides results in approximately 33 minutes with minimal hands-on time. The enclosed cartridge includes built-in separation layers, magnetic bead-based purification, and real-time fluorescence output for rapid identification of both Flu A and Flu B targets.

Key Features

• Targets: Influenza A and Influenza B RNA
• Technology: Isothermal nucleic acid amplification with real-time fluorescence detection
• Sample Types: Throat (oropharyngeal) swabs
• Time to Results: ~33 minutes
• Format: Fully automated cartridge, single-use
• Storage: 2–8°C
• Transportation: -25°C to 37°C within 15 days
• Shelf Life: 12 months from date of manufacture

Contents per Kit

Intended Use

For the qualitative detection and discrimination of Influenza A and B virus RNA in clinical throat swab samples. Not for self-testing or near-patient testing. For use by professional laboratory personnel only.